ArticleEuropean radiology2024

Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer.

Yuan Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.